- Home
- ADVM vs NEOV Comparison
ADVM vs NEOV Comparison
Compare ADVM & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- NEOV
- Stock Information
- Founded
- ADVM 2006
- NEOV 2018
- Country
- ADVM United States
- NEOV United States
- Employees
- ADVM N/A
- NEOV N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- NEOV Industrial Machinery/Components
- Sector
- ADVM Health Care
- NEOV Miscellaneous
- Exchange
- ADVM Nasdaq
- NEOV Nasdaq
- Market Cap
- ADVM 98.0M
- NEOV 111.3M
- IPO Year
- ADVM 2014
- NEOV N/A
- Fundamental
- Price
- ADVM $4.50
- NEOV $2.38
- Analyst Decision
- ADVM Strong Buy
- NEOV Strong Buy
- Analyst Count
- ADVM 6
- NEOV 1
- Target Price
- ADVM $27.83
- NEOV $7.50
- AVG Volume (30 Days)
- ADVM 189.1K
- NEOV 332.1K
- Earning Date
- ADVM 03-21-2025
- NEOV 05-09-2025
- Dividend Yield
- ADVM N/A
- NEOV N/A
- EPS Growth
- ADVM N/A
- NEOV N/A
- EPS
- ADVM N/A
- NEOV N/A
- Revenue
- ADVM $1,000,000.00
- NEOV $2,524,931.00
- Revenue This Year
- ADVM N/A
- NEOV $85.10
- Revenue Next Year
- ADVM $1,162.55
- NEOV $281.25
- P/E Ratio
- ADVM N/A
- NEOV N/A
- Revenue Growth
- ADVM N/A
- NEOV N/A
- 52 Week Low
- ADVM $3.52
- NEOV $0.63
- 52 Week High
- ADVM $18.50
- NEOV $6.11
- Technical
- Relative Strength Index (RSI)
- ADVM 51.62
- NEOV 34.80
- Support Level
- ADVM $4.20
- NEOV $2.54
- Resistance Level
- ADVM $4.91
- NEOV $3.29
- Average True Range (ATR)
- ADVM 0.49
- NEOV 0.42
- MACD
- ADVM 0.06
- NEOV -0.04
- Stochastic Oscillator
- ADVM 60.49
- NEOV 1.39
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.